Current Health to invest in coordinating in-home staffing, services. Read the announcement.
Current Health to invest in coordinating in-home staffing, services. Read the announcement.
54 peer-reviewed papers and abstracts in the last 36 months. Building the evidence base for safe, effective delivery of advanced treatments outside the hospital.
Developing and validating AI algorithms for early cytokine release syndrome detection. Understanding the physiological signatures that precede symptoms.
Validating virtual neurotoxicity assessment protocols. Developing remote ICE presentation and escalation criteria.
Building the evidence base for outpatient CAR-T and bispecific delivery. Defining eligibility criteria and monitoring protocols.
Characterizing real-world outcomes including response rates, adverse events, hospitalizations, and quality of life measures.
Quantifying cost savings from ambulatory delivery. Supporting value-based contracting with robust economic evidence.
Developing novel physiological signatures for early detection of adverse events. Training AI models on continuous biometric data.
Our internal research team collaborates with our partners to further the science and best practices of advanced therapy delivery beyond the hospital.
We work with partners to track standardized quality metrics, enabling continuous improvement and benchmarking.
Experience measures, patient-reported outcomes, and net promoter score
Percent of advanced therapy cases successfully delivered as outpatient
Time spent at home or hotel, time to hospitalization, financial impact
Clinical outcomes, safety metrics and rates of AEs, resource utilization
Impact of expanded inclusion criteria: distance, caregiver requirements, and decreased patient financial toxicity
Operational metrics and staff experience
